Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60yr of age Academic Article uri icon

Overview

MeSH Major

  • Antilymphocyte Serum
  • Graft Rejection
  • Graft Survival
  • Immunosuppressive Agents
  • Kidney Transplantation
  • Tissue Donors

abstract

  • Recipients over 60 yr receiving rATG induction have acceptable renal function and a low risk of rejection; however, reduced survival was noted among those receiving >6 mg/kg. These data suggest that when used, lower cumulative dosages of rATG are preferable in the older recipient.

publication date

  • May 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/j.1399-0012.2010.01393.x

PubMed ID

  • 21231963

Additional Document Info

start page

  • E250

end page

  • 6

volume

  • 25

number

  • 3